CONRAD applauds results of global iPrEx study
Successful trial provides proof of concept for oral use of antiretrovirals in preventing HIV infections in men who have sex with men
2010-11-24
(Press-News.org) ARLINGTON, VA-- NOVEMBER 23, 2010 - - CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention. Results of the National Institutes of Health (NIH) sponsored study were announced today in the New England Journal of Medicine. Daily use of the widely used antiretroviral combination pill was found to be an average of 44% effective in reducing risk of HIV infection in men who have sex with men (MSM), a historically high risk population. Among participants who took the pill at least 50% of the days, risk of HIV infection fell by 50.2%, and among those who used the pill on 90% or more of days, the antiretroviral reduced infection risk by 72.8% .
"This has been an incredible year for those of us working in the field of HIV prevention," said Dr. Henry Gabelnick, Executive Director of CONRAD. "The CAPRISA 004 trial of tenofovir gel broke new ground and now with the successful iPrEx trial, we have some great momentum here in terms of new options for HIV prevention."
The Phase III study of 2499 healthy, sexually active HIV-negative men was conducted at eleven locations in Peru, Ecuador, Boston, San Francisco, South Africa, Brazil and Thailand. The University of California, San Francisco conducted the study which was co-funded by NIH and the Bill and Melinda Gates Foundation, with study medication donated by Gilead Sciences. Pre-exposure prophylaxis (PrEP) is a strategy being studied in several trials as part of an effort to develop new HIV prevention tools. It is a therapy that has been used successfully by HIV-infected mothers during childbirth to reduce an infant's chance of contracting the virus by about 75 percent. Treatment with anti-HIV drugs can also significantly reduce the risk of infection when taken immediately after exposure to the virus.
CONRAD was one of the partners in the CAPRISA 004 study which evaluated 1% tenofovir gel in prevention of male-to-female HIV transmission and was the first study to show that a vaginal gel can reduce the risk of HIV and herpes infection in women. CONRAD manufactured and provided the tenofovir gel for the study. The FDA recently granted Fast Track approval designation for 1% tenofovir gel, and confirmed that the current NIH funded VOICE trial, conducted by the Microbicide Trials Network, can serve as a confirmatory study for the gel.
In 2006, CONRAD and IPM obtained a co-exclusive, royalty-free license from Gilead Sciences to develop 1% tenofovir gel as a topical microbicide for use by women in developing countries to prevent HIV.
INFORMATION:
For more information on the iPrEx study, go to: http://www.iprexnews.com
New England Journal of Medicine
R Grant et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine DOI 10.1056/NEJMoa1011205 (2010).
http://www.nejm.org/doi/full/10.1056/NEJMoa1011205
CONRAD (www.conrad.org) was established in 1986 and is a Division of the Department of Obstetrics and Gynecology at Eastern Virginia Medical School (EVMS) in Norfolk, VA, where it has laboratories and a clinical research center. The main office is located in Arlington, VA with additional offices in West Chester, PA and collaborators around the world. CONRAD is committed to improving reproductive health by researching and developing new contraceptive options and products to prevent HIV and STI infections.
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-24
If you're lucky, it will all be kisses and hugs around the Thanksgiving dinner table, with friends and family near and dear gathered about, and puppies gathered around your feet waiting for table scraps.
But peace won't reign within the confines of the oral cavity, where Streptococcus mutans and other harmful bacteria will await their own holiday feast. Your meal will enable S. mutans to launch one of its biggest assaults of the year on your tooth enamel.
New work by dental researchers at the University of Rochester Medical Center brings both good and bad news. While ...
2010-11-24
In many developing countries, forest restoration at home has led to deforestation abroad, according to a new study in the Proceedings of the National Academy of Sciences (PNAS).
The authors say their findings could have significant implications for ongoing efforts to protect the world's remaining forests, which are disappearing at an annual rate of more than 32 million acres – an area roughly the size of England.
"Reducing deforestation is an international priority, given its impacts on carbon emissions and biodiversity," said study co-author Eric Lambin of Stanford ...
2010-11-24
Ask the Eucalyptus connoisseurs
Koalas may be the pickiest marsupials around: They evolved to feed almost exclusively on the leaves of Eucalyptus trees, and they are highly selective when it comes to which species and even which individual trees they visit. When the furry leaf-eater settles on a particular tree, it relies on a number of factors, including taste, to make its selection. In a study published in the November issue of Ecology, a journal of the Ecological Society of America (ESA), researchers used koala feeding preferences to design a new method that could help ...
2010-11-24
Fuel cells could create a breakthrough for electric cars, because refuelling them is fast and easy, just like your traditional gas guzzler. But there's an obstacle. Current fuel cells need platinum in order to work. And that's expensive.
Now chemists from Copenhagen, Potsdam and Hanau have taken the first step towards producing fuel cells using very little of the precious metal.
At the University of Copenhagen Matthias Arenz has specialized in testing the catalysts that do the actual work in fuel cells. Presented with a so called "Core Shell catalyst" developed by Clarkson ...
2010-11-24
NEW YORK (Nov. 23, 2010) -- A hormone made by the body may be a potential therapeutic tool for the treatment of two anemic blood disorders -- beta-thalassemia and hemochromatosis. The new research was led by scientists at Weill Cornell Medical College and published in the Journal of Clinical Investigation and the journal Blood.
Commonly known as Cooley's anemia, beta-thalassemia affects nearly 1,000 individuals in the United States; worldwide, approximately 300,000 children are born each year with thalassemias. The conditions cause excessive iron absorption in the body's ...
2010-11-24
BATON ROUGE – LSU Professor Edward Shihadeh and Ph.D. candidate Raymond Barranco recently published a study titled "Latino Immigration, Economic Deprivation and Violence: Regional Differences in the Effect of Linguistic Isolation" in the journal Homicide Studies.
The researchers found that when Latinos in the United States lack English language capability, they are far more likely to be murdered. But this link between English language proficiency and victimization exists only in places where Latinos have settled recently – in places that the authors term "new Latino destinations." ...
2010-11-24
WASHINGTON — Earth and space science missions developed and implemented by federal agencies in collaboration typically result in additional complexity and cost and increased risks from divided responsibilities and accountability, says a new report from the National Research Council. Federal agencies should not partner in conducting space and earth science missions unless there is a compelling reason to do so and clear criteria are met in advance.
"A common misperception among policymakers and individual agencies is that collaboration on these missions will save money ...
2010-11-24
23 November 2010 (Geneva, Switzerland) – The International AIDS Society (IAS) cautiously notes the comments from Pope Benedict that condom use could, in specific circumstances, be acceptable, but calls on the Pope and the Catholic Church to come out clearly and strongly in support of all evidence-based methods of HIV prevention, including condom use.
By implying that there can only be some exceptional circumstances that could allow for condom usage, such as that of male prostitutes, the Pope is ignoring scientific evidence that shows that both male and female condoms, ...
2010-11-24
November 23, 2010 – Geneva, Switzerland – The International AIDS Society (IAS) calls on the Burmese Government to reverse a ruling made on November 18 to shut down a charitable HIV/AIDS clinic in Rangoon. The government demand came just one day after Aung San Suu Kyi, the recently released Nobel Peace Prize laureate visited the centre to show her support.
The clinic known as the HIV/AIDS Patients Care Center has been given up to November 25 to close. The Burmese Government has repealed the clinic's permit as well as refusing to renew residence permits to the 80 patients ...
2010-11-24
TORONTO, ON – Many people say they wouldn't cheat on a test, lie on a job application or refuse to help a person in need.
But what if the test answers fell into your lap and cheating didn't require any work on your part? If you didn't have to face the person who needed your help and refuse them? Would that change your behaviour?
New research out of the University of Toronto Scarborough shows it might. In two studies that tested participants' willingness to behave immorally, the UTSC team discovered people will behave badly – if it doesn't involve too much work on their ...
LAST 30 PRESS RELEASES:
[Press-News.org] CONRAD applauds results of global iPrEx study
Successful trial provides proof of concept for oral use of antiretrovirals in preventing HIV infections in men who have sex with men
